CX3CR1 and Alzheimer disease: Complementarily, Hemonnot-Girard et al. examined the impact of Cx3cr1 haplodeficiency in male and female APPswe/PSEN1dE9 mice across the early to more advanced stages of AD disease (Hemonnot-Girard et al., 2021).